Literature DB >> 901810

A spectrum of partially carboxylated prothrombins in the plasmas of coumarin-treated patients.

P A Friedman, R D Rosenberg, P V Hauschka, A Fitz-James.   

Abstract

Prothrombin has been purified from the plasmas of normal human donors and from patients ingesting coumarins. Equimolar amounts of normal prothrombin or coumadin-induced prothrombin were incubated with phospholipid micelles in the presence of Ca2+. Subsequent gel filtration of the incubation mixtures demonstrated that all of the normal prothrombin was bound to the phospholipid; only half of the coumadin-induced prothrombin was bound. Normal prothrombin contains approximately 10 mol of gamma-carboxyglutamic acid per mol of prothrombin. The coumadin-induced prothrombin which was bound to phospholipid contains approximately 6.5 mol of gamma-carboxyglutamic acid per mol of prothrombin while that which failed to bind to phospholipid has only 2.8 mol of gamma-carboxyglutamic acid per mol of zymogen. Thus, partially carboxylated prothrombins exist in the plasmas of coumarin-treated patients. Furthermore, there is a striking electrophoretic heterogeneity in the prothrombin preparations from the plasmas of the coumadin-treated patients. This most likely results from a wide spectrum of abnormal prothrombins with varying quantities of gamma-carboxyglutamic acid per mol of zymogen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901810     DOI: 10.1016/0005-2795(77)90155-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  [Role of vitamin K antagonists from a hepatologist's point of view].

Authors:  G Kneiseler; A Canbay; G Gerken
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

Review 3.  Warfarin in vulnerable older adults with atrial fibrillation.

Authors:  S Michael Gharacholou; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2009-05       Impact factor: 2.300

4.  Cooperativity in the calcium ion-induced quenching of the intrinsic fluorescence of a series of normal and GLA-deficient bovine prothrombin fragment 1 molecules.

Authors:  O P Malhotra; F Valencic; E T Fossel; K A Koehler
Journal:  J Protein Chem       Date:  1991-02

Review 5.  Algorithm for anticoagulation management in geriatric hip fracture patients--Surgeons save Blood.

Authors:  M A Wendl-Soeldner; C W I Moll; C Kammerlander; M Gosch; T Roth
Journal:  Z Gerontol Geriatr       Date:  2014-02       Impact factor: 1.281

Review 6.  Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis.

Authors:  Rasha Khatib; Maja Ludwikowska; Daniel M Witt; Jack Ansell; Nathan P Clark; Anne Holbrook; Wojtek Wiercioch; Holger Schünemann; Robby Nieuwlaat
Journal:  Blood Adv       Date:  2019-03-12

7.  Abnormal plasma prothrombin (PIVKA-II) levels in hepatocellular carcinoma.

Authors:  Y Kawaguchi
Journal:  Jpn J Surg       Date:  1989-05

Review 8.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

Review 10.  Reversal of oral anticoagulation.

Authors:  Jonathan L Thigpen; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2013-04-18       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.